NatureWise Biotech & Medicals Corp Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - NatureWise Biotech & Medicals Corp

Watchlist Manager

Watchlist

Price: 16 TWD -3.9% Market Closed

Market Cap: NT$791.7m

N	NatureWise Biotech & Medicals Corp TPEX:4732	TW

Profitability Summary

NatureWise Biotech & Medicals Corp's profitability score is 23/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

51%

Strong 3Y Average Gross Margin

53%

Declining Gross Margin

55% > 51%

Negative Operating Margin

-24%

Negative 3Y Average Operating Margin

-6%

Declining Operating Margin

6% > -24%

Negative Net Margin

-21%

Negative 3Y Average Net Margin

-2%

Declining Net Margin

9% > -21%

Negative Free Cash Flow Margin

-13%

Strong 3Y Average Free Cash Flow Margin

12%

Declining Free Cash Flow Margin

11% > -13%

Negative ROE

-6%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-7%

Declining ROIC

7% > -26%

View All

Hide

Collapse

23 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.